Global Tauopathies Treatment Market Growth (Status and Outlook) 2025-2031

January 2025 | 77 pages | ID: G9E92ABAAC7EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Tauopathies Treatment market size is predicted to grow from US$ 935 million in 2025 to US$ 1559 million in 2031; it is expected to grow at a CAGR of 8.9% from 2025 to 2031.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Tauopathies Treatment Industry Forecast” looks at past sales and reviews total world Tauopathies Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Tauopathies Treatment sales for 2025 through 2031. With Tauopathies Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tauopathies Treatment industry.

This Insight Report provides a comprehensive analysis of the global Tauopathies Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tauopathies Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tauopathies Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tauopathies Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tauopathies Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Tauopathies Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• SEL-141
• RDC-5
• YM-08
• Thiamet-G
• Others

Segmentation by Application:

• Clinic
• Hospital
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bristol-Myers Squibb Company
• Selvita S.A
• SK Biopharmaceuticals Co., Ltd.
• Chronos Therapeutics Limited

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tauopathies Treatment Market Size (2020-2031)
  2.1.2 Tauopathies Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Tauopathies Treatment by Country/Region (2020, 2024 & 2031)
2.2 Tauopathies Treatment Segment by Type
  2.2.1 SEL-141
  2.2.2 RDC-5
  2.2.3 YM-08
  2.2.4 Thiamet-G
  2.2.5 Others
2.3 Tauopathies Treatment Market Size by Type
  2.3.1 Tauopathies Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Tauopathies Treatment Market Size Market Share by Type (2020-2025)
2.4 Tauopathies Treatment Segment by Application
  2.4.1 Clinic
  2.4.2 Hospital
  2.4.3 Others
2.5 Tauopathies Treatment Market Size by Application
  2.5.1 Tauopathies Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Tauopathies Treatment Market Size Market Share by Application (2020-2025)

3 TAUOPATHIES TREATMENT MARKET SIZE BY PLAYER

3.1 Tauopathies Treatment Market Size Market Share by Player
  3.1.1 Global Tauopathies Treatment Revenue by Player (2020-2025)
  3.1.2 Global Tauopathies Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Tauopathies Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TAUOPATHIES TREATMENT BY REGION

4.1 Tauopathies Treatment Market Size by Region (2020-2025)
4.2 Global Tauopathies Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tauopathies Treatment Market Size Growth (2020-2025)
4.4 APAC Tauopathies Treatment Market Size Growth (2020-2025)
4.5 Europe Tauopathies Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Tauopathies Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Tauopathies Treatment Market Size by Country (2020-2025)
5.2 Americas Tauopathies Treatment Market Size by Type (2020-2025)
5.3 Americas Tauopathies Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tauopathies Treatment Market Size by Region (2020-2025)
6.2 APAC Tauopathies Treatment Market Size by Type (2020-2025)
6.3 APAC Tauopathies Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Tauopathies Treatment Market Size by Country (2020-2025)
7.2 Europe Tauopathies Treatment Market Size by Type (2020-2025)
7.3 Europe Tauopathies Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tauopathies Treatment by Region (2020-2025)
8.2 Middle East & Africa Tauopathies Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Tauopathies Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TAUOPATHIES TREATMENT MARKET FORECAST

10.1 Global Tauopathies Treatment Forecast by Region (2026-2031)
  10.1.1 Global Tauopathies Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Tauopathies Treatment Forecast
  10.1.3 APAC Tauopathies Treatment Forecast
  10.1.4 Europe Tauopathies Treatment Forecast
  10.1.5 Middle East & Africa Tauopathies Treatment Forecast
10.2 Americas Tauopathies Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Tauopathies Treatment Forecast
  10.2.2 Canada Market Tauopathies Treatment Forecast
  10.2.3 Mexico Market Tauopathies Treatment Forecast
  10.2.4 Brazil Market Tauopathies Treatment Forecast
10.3 APAC Tauopathies Treatment Forecast by Region (2026-2031)
  10.3.1 China Tauopathies Treatment Market Forecast
  10.3.2 Japan Market Tauopathies Treatment Forecast
  10.3.3 Korea Market Tauopathies Treatment Forecast
  10.3.4 Southeast Asia Market Tauopathies Treatment Forecast
  10.3.5 India Market Tauopathies Treatment Forecast
  10.3.6 Australia Market Tauopathies Treatment Forecast
10.4 Europe Tauopathies Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Tauopathies Treatment Forecast
  10.4.2 France Market Tauopathies Treatment Forecast
  10.4.3 UK Market Tauopathies Treatment Forecast
  10.4.4 Italy Market Tauopathies Treatment Forecast
  10.4.5 Russia Market Tauopathies Treatment Forecast
10.5 Middle East & Africa Tauopathies Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Tauopathies Treatment Forecast
  10.5.2 South Africa Market Tauopathies Treatment Forecast
  10.5.3 Israel Market Tauopathies Treatment Forecast
  10.5.4 Turkey Market Tauopathies Treatment Forecast
10.6 Global Tauopathies Treatment Forecast by Type (2026-2031)
10.7 Global Tauopathies Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Tauopathies Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bristol-Myers Squibb Company
  11.1.1 Bristol-Myers Squibb Company Company Information
  11.1.2 Bristol-Myers Squibb Company Tauopathies Treatment Product Offered
  11.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Bristol-Myers Squibb Company Main Business Overview
  11.1.5 Bristol-Myers Squibb Company Latest Developments
11.2 Selvita S.A
  11.2.1 Selvita S.A Company Information
  11.2.2 Selvita S.A Tauopathies Treatment Product Offered
  11.2.3 Selvita S.A Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Selvita S.A Main Business Overview
  11.2.5 Selvita S.A Latest Developments
11.3 SK Biopharmaceuticals Co., Ltd.
  11.3.1 SK Biopharmaceuticals Co., Ltd. Company Information
  11.3.2 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Product Offered
  11.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 SK Biopharmaceuticals Co., Ltd. Main Business Overview
  11.3.5 SK Biopharmaceuticals Co., Ltd. Latest Developments
11.4 Chronos Therapeutics Limited
  11.4.1 Chronos Therapeutics Limited Company Information
  11.4.2 Chronos Therapeutics Limited Tauopathies Treatment Product Offered
  11.4.3 Chronos Therapeutics Limited Tauopathies Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Chronos Therapeutics Limited Main Business Overview
  11.4.5 Chronos Therapeutics Limited Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1.TauopathiesTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2.TauopathiesTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of SEL-141
Table 4. Major Players of RDC-5
Table 5. Major Players of YM-08
Table 6. Major Players ofThiamet-G
Table 7. Major Players of Others
Table 8.TauopathiesTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 9. GlobalTauopathiesTreatment Market Size byType (2020-2025) & ($ millions)
Table 10. GlobalTauopathiesTreatment Market Size Market Share byType (2020-2025)
Table 11.TauopathiesTreatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. GlobalTauopathiesTreatment Market Size by Application (2020-2025) & ($ millions)
Table 13. GlobalTauopathiesTreatment Market Size Market Share by Application (2020-2025)
Table 14. GlobalTauopathiesTreatment Revenue by Player (2020-2025) & ($ millions)
Table 15. GlobalTauopathiesTreatment Revenue Market Share by Player (2020-2025)
Table 16.TauopathiesTreatment Key Players Head office and Products Offered
Table 17.TauopathiesTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. GlobalTauopathiesTreatment Market Size by Region (2020-2025) & ($ millions)
Table 21. GlobalTauopathiesTreatment Market Size Market Share by Region (2020-2025)
Table 22. GlobalTauopathiesTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. GlobalTauopathiesTreatment Revenue Market Share by Country/Region (2020-2025)
Table 24. AmericasTauopathiesTreatment Market Size by Country (2020-2025) & ($ millions)
Table 25. AmericasTauopathiesTreatment Market Size Market Share by Country (2020-2025)
Table 26. AmericasTauopathiesTreatment Market Size byType (2020-2025) & ($ millions)
Table 27. AmericasTauopathiesTreatment Market Size Market Share byType (2020-2025)
Table 28. AmericasTauopathiesTreatment Market Size by Application (2020-2025) & ($ millions)
Table 29. AmericasTauopathiesTreatment Market Size Market Share by Application (2020-2025)
Table 30. APACTauopathiesTreatment Market Size by Region (2020-2025) & ($ millions)
Table 31. APACTauopathiesTreatment Market Size Market Share by Region (2020-2025)
Table 32. APACTauopathiesTreatment Market Size byType (2020-2025) & ($ millions)
Table 33. APACTauopathiesTreatment Market Size by Application (2020-2025) & ($ millions)
Table 34. EuropeTauopathiesTreatment Market Size by Country (2020-2025) & ($ millions)
Table 35. EuropeTauopathiesTreatment Market Size Market Share by Country (2020-2025)
Table 36. EuropeTauopathiesTreatment Market Size byType (2020-2025) & ($ millions)
Table 37. EuropeTauopathiesTreatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & AfricaTauopathiesTreatment Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & AfricaTauopathiesTreatment Market Size byType (2020-2025) & ($ millions)
Table 40. Middle East & AfricaTauopathiesTreatment Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities ofTauopathiesTreatment
Table 42. Key Market Challenges & Risks ofTauopathiesTreatment
Table 43. Key IndustryTrends ofTauopathiesTreatment
Table 44. GlobalTauopathiesTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 45. GlobalTauopathiesTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 46. GlobalTauopathiesTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 47. GlobalTauopathiesTreatment Market SizeForecast by Application (2026-2031) & ($ millions)
Table 48. Bristol-Myers Squibb Company Details, CompanyType,TauopathiesTreatment Area Served and Its Competitors
Table 49. Bristol-Myers Squibb CompanyTauopathiesTreatment Product Offered
Table 50. Bristol-Myers Squibb CompanyTauopathiesTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Bristol-Myers Squibb Company Main Business
Table 52. Bristol-Myers Squibb Company Latest Developments
Table 53. Selvita S.A Details, CompanyType,TauopathiesTreatment Area Served and Its Competitors
Table 54. Selvita S.ATauopathiesTreatment Product Offered
Table 55. Selvita S.ATauopathiesTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Selvita S.A Main Business
Table 57. Selvita S.A Latest Developments
Table 58. SK Biopharmaceuticals Co., Ltd. Details, CompanyType,TauopathiesTreatment Area Served and Its Competitors
Table 59. SK Biopharmaceuticals Co., Ltd.TauopathiesTreatment Product Offered
Table 60. SK Biopharmaceuticals Co., Ltd.TauopathiesTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. SK Biopharmaceuticals Co., Ltd. Main Business
Table 62. SK Biopharmaceuticals Co., Ltd. Latest Developments
Table 63. ChronosTherapeutics Limited Details, CompanyType,TauopathiesTreatment Area Served and Its Competitors
Table 64. ChronosTherapeutics LimitedTauopathiesTreatment Product Offered
Table 65. ChronosTherapeutics LimitedTauopathiesTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. ChronosTherapeutics Limited Main Business
Table 67. ChronosTherapeutics Limited Latest Developments



LIST OFFIGURES

Figure 1.TauopathiesTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. GlobalTauopathiesTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6.TauopathiesTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7.TauopathiesTreatment Sales Market Share by Country/Region (2024)
Figure 8.TauopathiesTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. GlobalTauopathiesTreatment Market Size Market Share byType in 2024
Figure 10.TauopathiesTreatment in Clinic
Figure 11. GlobalTauopathiesTreatment Market: Clinic (2020-2025) & ($ millions)
Figure 12.TauopathiesTreatment in Hospital
Figure 13. GlobalTauopathiesTreatment Market: Hospital (2020-2025) & ($ millions)
Figure 14.TauopathiesTreatment in Others
Figure 15. GlobalTauopathiesTreatment Market: Others (2020-2025) & ($ millions)
Figure 16. GlobalTauopathiesTreatment Market Size Market Share by Application in 2024
Figure 17. GlobalTauopathiesTreatment Revenue Market Share by Player in 2024
Figure 18. GlobalTauopathiesTreatment Market Size Market Share by Region (2020-2025)
Figure 19. AmericasTauopathiesTreatment Market Size 2020-2025 ($ millions)
Figure 20. APACTauopathiesTreatment Market Size 2020-2025 ($ millions)
Figure 21. EuropeTauopathiesTreatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & AfricaTauopathiesTreatment Market Size 2020-2025 ($ millions)
Figure 23. AmericasTauopathiesTreatment Value Market Share by Country in 2024
Figure 24. United StatesTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 25. CanadaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 26. MexicoTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 27. BrazilTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APACTauopathiesTreatment Market Size Market Share by Region in 2024
Figure 29. APACTauopathiesTreatment Market Size Market Share byType (2020-2025)
Figure 30. APACTauopathiesTreatment Market Size Market Share by Application (2020-2025)
Figure 31. ChinaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 32. JapanTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South KoreaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast AsiaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 35. IndiaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 36. AustraliaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. EuropeTauopathiesTreatment Market Size Market Share by Country in 2024
Figure 38. EuropeTauopathiesTreatment Market Size Market Share byType (2020-2025)
Figure 39. EuropeTauopathiesTreatment Market Size Market Share by Application (2020-2025)
Figure 40. GermanyTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 41.FranceTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UKTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 43. ItalyTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 44. RussiaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & AfricaTauopathiesTreatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & AfricaTauopathiesTreatment Market Size Market Share byType (2020-2025)
Figure 47. Middle East & AfricaTauopathiesTreatment Market Size Market Share by Application (2020-2025)
Figure 48. EgyptTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South AfricaTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 50. IsraelTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 51.TurkeyTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC CountriesTauopathiesTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53. AmericasTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 54. APACTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 55. EuropeTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & AfricaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 57. United StatesTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 58. CanadaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 59. MexicoTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 60. BrazilTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 61. ChinaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 62. JapanTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 63. KoreaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast AsiaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 65. IndiaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 66. AustraliaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 67. GermanyTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 68.FranceTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 69. UKTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 70. ItalyTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 71. RussiaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 72. EgyptTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 73. South AfricaTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 74. IsraelTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 75.TurkeyTauopathiesTreatment Market Size 2026-2031 ($ millions)
Figure 76. GlobalTauopathiesTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 77. GlobalTauopathiesTreatment Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC CountriesTauopathiesTreatment Market Size 2026-2031 ($ millions)